VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.
about
Selective gene silencing by viral delivery of short hairpin RNAThe dicey role of Dicer: implications for RNAi therapyTherapeutic application of RNAi: is mRNA targeting finally ready for prime time?shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapyAnti-angiogenic gene therapy in the treatment of malignant gliomasRNAi reduces expression and intracellular retention of mutant cartilage oligomeric matrix protein.Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo.Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumorOncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic virusesPolynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitorsA novel sLRP6E1E2 inhibits canonical Wnt signaling, epithelial-to-mesenchymal transition, and induces mitochondria-dependent apoptosis in lung cancer.Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA.Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF.Increasing the efficacy of oncolytic adenovirus vectorsAdenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cellsEnhancing the therapeutic efficacy of adenovirus in combination with biomaterials.Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virusLinearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymers.Polymeric oncolytic adenovirus for cancer gene therapy.Novel delivery methods to achieve immunomodulation.Targeting tumor vasculature through oncolytic virotherapy: recent advances.Advances in oncolytic virus therapy for glioma.Armed replicating adenoviruses for cancer virotherapy.Adenoviral vector-based strategies for cancer therapy.RNA interference as an anticancer therapy: a patent perspective.Strategies for short hairpin RNA delivery in cancer gene therapy."Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.Oncolytic (replication-competent) adenoviruses as anticancer agents.Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy.Oncolytic-adenovirus-expressed RNA interference for cancer therapy.Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.Human Noxin is an anti-apoptotic protein in response to DNA damage of A549 non-small cell lung carcinoma.RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies.Targeting Melanoma with Cancer-Killing Viruses.Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.Adenoviral vector-based strategies against infectious disease and cancer.Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.Efficient lung orthotopic tumor-growth suppression of oncolytic adenovirus complexed with RGD-targeted bioreducible polymer.Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy.Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF.
P2860
Q21245112-4526FAD8-7A0C-4D7E-A04E-3777A80A0F2EQ24597854-4BE19A7D-CFA8-4B2A-906C-0CEA0869B85CQ24669624-B026A1C2-8DD5-4761-936F-3492A022FCD7Q26765364-0FBEA472-54DD-417D-A841-42FAAAB7FB78Q26866276-1BFB687D-9020-4CD4-9896-BD15E0029A2FQ33565464-7E6ACF29-814E-4551-97E1-6AD27096B553Q33690926-D0430C6B-FEEA-486B-A58D-BF55D7718A03Q33739293-35C34257-06A8-444C-90FE-0ABB1A251902Q33924550-8FC4B800-CDCA-47D0-A139-532572E3AE5CQ34231660-9F0AAF00-09D6-4437-91A2-C6833380A907Q34273617-670397D9-4C83-4DAA-B4C7-4F5AFA095C5FQ35000513-A0AF5A0F-EA50-40EF-9BC4-29D6B79EF86FQ35144428-3085CF6D-6601-43BA-9E6D-5B449BC0CAF5Q35261325-33849BDF-E9E4-4F50-98D9-2B0A73BFB225Q35551938-11AE9DB9-9009-4727-9706-E11CB5971ACDQ35624010-27E94296-4891-4B66-89AA-80B50DBD0CF6Q35750059-5F7BB949-CBB7-4979-AAFC-93A1A7D2382CQ35869766-8EC55124-CEEA-40F5-A18E-40B9CFE62B00Q36344901-6F8F5346-EA92-43EB-B6BF-6FB313D46F24Q36870418-F388526A-B915-4E39-814E-B53966A54A3AQ37031932-0AFED915-EF8B-4AD3-A9D0-2AFADA8633B9Q37287118-AC39E386-E074-45BD-9A89-44FFAA4D21F0Q37386616-EDCDB7AD-116D-4181-BB72-487955797FAFQ37409025-A8784D1E-FA8D-4081-8089-D5E9595F8D60Q37481329-97706B18-A5F2-4748-B4FD-34B0C77506BCQ37598928-D2BE0629-1B40-4560-8D08-E38B871E579BQ37622288-1299B272-B0B2-4516-A9F9-1A33ADEB2400Q37687415-A4355457-8A48-44F2-A4FF-F074E94F32BFQ37709052-AFB4B189-968F-48AB-BCCE-7E13C2A4C83EQ37777745-FA7285FD-D803-4D6F-A65F-3333E551284BQ37804933-6F112752-E328-4216-9C62-92504D955C4AQ38311315-FF905AC3-D58F-430D-8DF7-E9578D67F7BCQ38541950-503E9C6B-C644-48E0-B970-3BD868CE95C6Q38676416-8A378615-D08A-4A68-8619-A2B3E12CEE44Q38769919-2D53F874-17B9-43F6-84C9-ABBC1FF1E525Q38814885-AE3C9202-14E7-4327-8AB0-81480EC5285CQ38848060-0360189E-A26C-47C8-B77B-A4D8232DBEEBQ39018330-D75BD705-95A3-4941-9A6B-C6CF9BFC5473Q39178068-86B73060-6C8F-49AE-B397-C3D2FCE726A8Q39459281-94B95736-FF33-476E-93CC-1A7C33B365F7
P2860
VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
VEGF-specific short hairpin RN ...... angiogenesis and tumor growth.
@en
type
label
VEGF-specific short hairpin RN ...... angiogenesis and tumor growth.
@en
prefLabel
VEGF-specific short hairpin RN ...... angiogenesis and tumor growth.
@en
P2093
P356
P1433
P1476
VEGF-specific short hairpin RN ...... angiogenesis and tumor growth
@en
P2093
Eok-Cheon Kim
Ji Young Yoo
Joo-Hang Kim
Nam Kyu Kim
Young-Guen Kwon
P304
P356
10.1038/SJ.MT.6300023
P577
2007-02-01T00:00:00Z